Advertisement
|
|
|
|
|
Free Trial
Description: Allen Sussman is Rainier Clinical Research Center Founder. With a Lead411 subscription, Rainier Clinical Research Center email addresses ( @rainier-research.com ) of the executives are viewable. Other information includes Allen Sussman email, phone, and extension.
We provide information from your LinkedIn network, see company profile, and soon we will be showing twitter and facebook profiles as well. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to Sussman can be found at Executive Directory - Sussman.
|
Add Allen Sussman Information
Site Reference: http://www.rainier-research.com/clinicaltrials6.html#top
Allen Sussman MD A l-Year, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of an Investigational Medication in NIDDM Patients With Hyperlipidemia 1993-94 PI - Ronald Brazg, MD A One Year, Multicenter-Center, Double-blind, Randomized, Parallel Group Comparison Extension Study To Investigate the Long-Term Efficacy, Tolerability and Safety of an Investigational Medication in Three Different Doses in the Treatment of Patients With Non-Insulin-Dependent Diabetes Mellitus (NIDDM) who Have Satisfactorily Completed The Double-blind Treatment Phase of Study 1993 PI - Allen Sussman, MD A Multi-Center, Double-blind, Placebo-Controlled Group Comparison Study to Investigate the Efficacy, Tolerability and Safety of an Investigational Medication as Compared to a Fixed Dose of Sulfonylurea, Alone and in Combination With an Investigational Medication, in the Treatment of Patients With Mild Non-Insulin-Dependent Diabetes Mellitus (Type II) Inadequately Controlled With Diet Alone. 1993 PI - Allen Sussman, MD A One-Year, Multicenter, Double-blind, Randomized, Parallel M.D. Randomized, Comparative Evaluation Of The Efficacy and Safety Of an investigational medication Versus Glipizide in Patients With Non-Insulin Dependent Diabetes Mellitus DIABETES DEVICE STUDIES 2006- PI – Ronald Brazg, MD Clinical Study of Perceived Pain with An Investigational Continuous Glucose Monitoring System Compared to Lifescan and Roche Blood Glucose Monitoring Systems. 2005 –PI – Ronald Brazg, MD Clinical Evaluation of the Accuracy of An Investigational Continuous Glucose Monitoring System 2005 –PI – Ronald Brazg, MD Clinical Evaluation of the Accuracy of An Investigational Continuous Glucose Monitoring System 2005– PI – Leslie Klaff, MD, Ph.D Multi-Center, Randomized, Home-Use Study of the Investigational 31 Gauge Thin, Wall x3mm Pen Needle and Currently Marketed 31 Gauge, Thin Wall x 5mm Pen Needle To Compare Glycemic Control in Subjects with Diabetes Mellitus 2004 – PI – Ronald Brazg, MD Clinical Evaluation
|
|
| Copyright 2010 Lead411 | Santa Barbara, CA |
|
|
|
|
Advertisement
|
